<a id='ad35cbf1-49eb-43ae-898f-469659bd11f0'></a>

NUTRITION SUPPORT CERTIFICATE

<a id='530d4173-8d9d-40a2-852f-7a53dfe969d4'></a>

# *Acid-Base Disorders*

<a id='2507e64c-33ef-47a4-8f30-e3742f4e0f88'></a>

<::logo: ASHP
ashp®
The logo features the word "ashp" in bold, italicized blue text with an orange swoosh above the 'h' and 'p'.::>

<a id='9e5b9d68-afb2-47b8-9e93-ffa7b3e5359e'></a>

CAPTION ERROR

<a id='4e61a49d-cb8b-4dbb-be8f-5b85a8f123bf'></a>

Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).

<a id='f7d7cf12-7bad-47d4-b40c-d04d5cabd381'></a>

©2022 American Society of Health-System Pharmacists, Inc. All rights reserved.
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval
system, without written permission from the American Society of Health-System Pharmacists.

<a id='9ccde4e7-d349-46d9-8cda-39ed7fb7fbd7'></a>

NUTRITION SUPPORT
COMPLICATIONS:
ACID-BASE
DISORDERS

Anne M. Tucker, Pharm.D., BCNSP
University of Texas MD Anderson Cancer Center

NUTRITION SUPPORT
CERTIFICATE

ashp aspen

<a id='5fb802e7-4afe-4c8b-b7e7-4493bc7acbdb'></a>

RELEVANT FINANCIAL
RELATIONSHIP DISCLOSURE

<a id='8495784b-4553-4f30-9af0-d85056fd23a0'></a>

The following persons in control of this activity's content have relevant financial
relationships:

*   Jay Mirtallo: Fresenius Kabi, consultant

All other persons in control of content do not have any relevant financial
relationships with an ineligible company.

As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial
relationships have been mitigated prior to the CPE activity.

<a id='039ba1c0-a754-4cfd-a9a6-40e493e7d741'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='7d6d2a8b-7013-42aa-972a-7fc9c386e4a4'></a>

# LEARNING OBJECTIVES

* Analyze patient information to determine type acid-base disorder.
* Describe common etiologies of acid-base disorders and their impact on the nutrition prescription.
* Design recommendations for the prevention and management of acid-base disorders.

NUTRITION SUPPORT
CERTIFICATE

<a id='12e7b8ef-ce60-4c1b-8c93-230bed884a2c'></a>

# KEY ABBREVIATIONS

*   ABG: arterial blood gas
*   AG: anion gap
*   BUN: blood urea nitrogen
*   Ca: calcium
*   Cl: chloride
*   CO2: carbon dioxide
*   COPD: chronic obstructive pulmonary disease
*   ECF: extracellular fluid
*   H+: hydrogen ion
*   HCO3: bicarbonate

NUTRITION SUPPORT
CERTIFICATE

<a id='ad7a885a-0da5-4a19-ba65-9b2dbbfee8a2'></a>

KEY ABBREVIATIONS, CONT.

*   ICF: intracellular fluid
*   K: potassium
*   Mg: magnesium
*   Na: sodium
*   NG: nasogastric
*   P: phosphorus
*   pCO2: partial pressure of carbon dioxide
*   PN: parenteral nutrition
*   pO2: partial pressure of oxygen
*   uCl: urine chloride

NUTRITION SUPPORT
CERTIFICATE

<a id='a8d1fa27-7ffe-466d-a04e-9915b0a97a78'></a>

CAPTION ERROR

<a id='b3f95561-16d4-46ba-ada9-6cc939c267ec'></a>

- RK is a 55 year old male home PN patient who presents to the Emergency Department for hypovolemia secondary to multiple days of high volume emesis.
- Laboratory values:

<a id='b1df02d1-2311-4d30-a9ad-050c439895a8'></a>

<table id="3-1">
<tr><td id="3-2">Na: 139 mEq/L</td><td id="3-3">Glucose: 122 mg/dL</td></tr>
<tr><td id="3-4">K: 3.7 mEq/L</td><td id="3-5">ABG:</td></tr>
<tr><td id="3-6">Cl: 98 mEq/L</td><td id="3-7">pH: 7.46</td></tr>
<tr><td id="3-8">CO2: 34 mEq/L</td><td id="3-9">pCO2: 46 mmHg</td></tr>
<tr><td id="3-a">BUN: 21 mg/dL</td><td id="3-b">PO2: 92 mmHg</td></tr>
<tr><td id="3-c">Cr: 0.9 mg/dL</td><td id="3-d">HCO₃: 34 mmol/L</td></tr>
</table>

<a id='a53e1d9f-5382-4121-ae5c-30ef952465a1'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='ef8e867d-086c-47d4-9e04-e9a328024398'></a>

CAPTION ERROR

<a id='3e39c65a-1200-4454-9fc3-8c7e310bcbb4'></a>

Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?

A. Initiate mechanical ventilation
B. Increase chloride salts in the PN
C. Increase acetate salts in the PN
D. Decrease calorie content of PN

NUTRITION SUPPORT
CERTIFICATE

<a id='eca348a1-bf37-4145-83b2-103c3f3da3d4'></a>

GENERAL PRINCIPLES - PH

*   The degree of acidity in the blood
*   Acidity of the blood is based on the hydrogen ion (H+) concentration
*   pH is maintained at 7.40 (7.35 to 7.45)
*   Associated disorders
    *   Acidosis: lead to pH < 7.35
    *   Alkalosis: lead to pH > 7.45

<a id='641f6fc8-86cb-4131-b5e3-0412d49c9a94'></a>

Ayers P et al. JPEN J Parent Enteral Nutr. 2012; 36:18-23.

<a id='f794d0a4-aeb2-4dfc-8336-d9c8dc8d535e'></a>

<::A brown banner with a dark brown base and a lighter brown top edge, sloping upwards from left to right. The text "NUTRITION SUPPORT CERTIFICATE" is centered on the right side of the banner.: figure::>

<a id='43711656-a9f4-40b5-a366-cb0cd869d616'></a>

## GENERAL PRINCIPLES – H+

* Regulation via 3 mechanisms
  - Chemical buffering by extracellular and intracellular mechanisms
  - Control of pCO₂ in the blood by the lungs via alterations in the rate and depth of ventilation
  - Control of the serum HCO₃⁻ concentration by alterations in renal H+ excretion and HCO₃⁻ reabsorption

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue, HJ et al. Kidney Int. 2009; 76:1239–47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104–11.

NUTRITION SUPPORT
CERTIFICATE

<a id='f5228bb4-0199-40f9-b0b7-d0f8c34040db'></a>

## GENERAL PRINCIPLES - BUFFERS

*   Most abundant ECF buffer
    *   Carbonic acid/bicarbonate system

    H₂O + CO₂ <=> H₂CO₃ <=> H⁺ + HCO₃⁻
    Carbonic acid Bicarbonate

*   ~15,000 mmol CO₂ produced daily from fat and carbohydrate metabolism
*   Lungs eliminate to prevent buildup of CO₂
*   Other buffers: plasma proteins, hemoglobin, phosphates

Ayers P et al. JPEN J Parent Enteral Nutr. 2012; 36:18-23.

NUTRITION SUPPORT
CERTIFICATE

<a id='ba3b0abb-2d3b-40c8-8041-64cb07426ce6'></a>

ACID-BASE GENERAL PRINCIPLES

*   Described by the Henderson-Hasselbalch equation
*   pH = 6.1 + log ([HCO₃⁻] / (0.03 x pCO₂))
    *   HCO₃⁻
        *   Base component
        *   Calculated from arterial pH and pCO₂
    *   pCO₂
        *   Acid component
        *   Measured in serum

Ayers P et al. JPEN J Parent Enteral Nutr. 2012; 36:18-23.

NUTRITION SUPPORT
CERTIFICATE

<a id='2fad08c3-449a-4f8a-9883-01f3e0da43c9'></a>

## ARTERIAL BLOOD GAS (ABG)

*   Laboratory analysis that reflects the ability of the lungs to oxygenate blood
*   pH/pCO₂/pO₂/HCO₃⁻

<table><thead><tr><th></th><th>Normal ABG values</th></tr></thead><tbody><tr><td>pH</td><td>7.40 (7.35 – 7.45)</td></tr><tr><td>pCO₂ (mm Hg)</td><td>40 (35 – 45)</td></tr><tr><td>pO₂ (mm Hg)</td><td>80 – 100</td></tr><tr><td>HCO₃⁻ (mEq/L)</td><td>24 (22 – 26)</td></tr></tbody></table>

Ayers P et al. JPEN J Parent Enteral Nutr. 2012; 36:18-23.

NUTRITION SUPPORT
CERTIFICATE

<a id='439d993b-82ee-472a-9a4e-da1cefb757c3'></a>

ACID-BASE DISORDERS

*   Metabolic acidosis
*   Metabolic alkalosis
*   Respiratory acidosis
*   Respiratory alkalosis
*   Mixed disorders

NUTRITION SUPPORT
CERTIFICATE

<a id='854ad5ab-0c7f-4cdf-8f0c-34394c66fef7'></a>

METABOLIC DISORDERS

*   Result from disturbances in plasma HCO₃⁻
*   Regulated by the kidneys
*   HCO₃⁻ is the basic component in the carbonic acid/bicarbonate buffer system
*   Normal value 24 mmol/L (range 22-26 mmol/L)
    *   Metabolic acidosis HCO₃⁻ is < 24
    *   Metabolic alkalosis HCO₃⁻ is > 24

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='e5e44967-215d-4859-aa5e-3ba47ab31a78'></a>

## RESPIRATORY DISORDERS

*   Alterations in alveolar ventilation leading to changes in PCO₂
*   pCO₂ is the acidic component in the carbonic acid/bicarbonate buffer system
*   Normal value 40 mmHg (range 35-45 mmHg)
    *   Respiratory acidosis pCO₂ is > 40
    *   Respiratory alkalosis pCO₂ is < 40

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239–47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='df00a1f7-553e-403f-8fba-dc3bafa76bd9'></a>

COMPENSATION

*   Metabolic disorders
    *   Lungs regulate pCO₂ by altering the rate and depth of ventilation
    *   Excretion of CO₂ generated by diet and cellular metabolism
    *   Compensation starts within minutes
*   Respiratory disorders
    *   Kidneys regulate HCO₃⁻ via alterations in renal HCO₃⁻ excretion
    *   Compensation fully activated in 2 – 3 days

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239–47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='399d1400-17a7-401b-a9f3-cb5c574614d0'></a>

<::A brown banner with the text "PUTTING IT TOGETHER" and a white line-art illustration of a person's head/neck with a medical tube entering the mouth/nose area, connected to an IV bag. : illustration::>

<a id='62d2e683-85b7-48a9-87e5-702b97f9d4d6'></a>

<table id="9-1">
<tr><td id="9-2">Acid-Base Disorder</td><td id="9-3">pH</td><td id="9-4">Primary Disturbance</td><td id="9-5">Compensatory Response</td></tr>
<tr><td id="9-6" colspan="4">Respiratory</td></tr>
<tr><td id="9-7">Acidosis</td><td id="9-8">↓</td><td id="9-9">↑ PCO₂</td><td id="9-a">↑ HCO₃⁻</td></tr>
<tr><td id="9-b">Alkalosis</td><td id="9-c">↑</td><td id="9-d">↓ PCO₂</td><td id="9-e">↓ HCO₃⁻</td></tr>
<tr><td id="9-f" colspan="4">Metabolic</td></tr>
<tr><td id="9-g">Acidosis</td><td id="9-h">↓</td><td id="9-i">↓ HCO₃</td><td id="9-j">↓ PCO₂</td></tr>
<tr><td id="9-k">Alkalosis</td><td id="9-l">↑</td><td id="9-m">↑ HCO₃</td><td id="9-n">↑ PCO₂</td></tr>
</table>

<a id='f92808a2-647e-4493-bd22-8a3342cefcdd'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='e78588a0-b4c2-427b-bd79-0bb61d7ce8af'></a>

COMPENSATION FORMULAS
<table id="9-o">
<tr><td id="9-p">Disorder</td><td id="9-q">Compensation Formula</td></tr>
<tr><td id="9-r">Metabolic acidosis</td><td id="9-s">Expected pCO₂ = 40 - [1.2 x (24 - measured HCO₃⁻)]</td></tr>
<tr><td id="9-t">Metabolic alkalosis</td><td id="9-u">Expected pCO₂ = 40 + [0.7 x (measured HCO₃⁻ - 24)]</td></tr>
<tr><td id="9-v">Acute respiratory acidosis</td><td id="9-w">Expected decrease in pH = 0.08 x (measured pCO₂ – 40) / 10</td></tr>
<tr><td id="9-x">Chronic respiratory acidosis</td><td id="9-y">Expected decrease in pH = 0.03 x (measured pCO₂ - 40) / 10</td></tr>
<tr><td id="9-z">Acute respiratory alkalosis</td><td id="9-A">Expected increase in pH = 0.08 x (40 - measured pCO2) 10</td></tr>
<tr><td id="9-B">Chronic respiratory alkalosis</td><td id="9-C">Expected increase in pH = 0.03 x (40 - measured pCO2) 10</td></tr>
<tr><td id="9-D" colspan="2">*Expected values should be within 10% of actual to determine simple disorders</td></tr>
</table>

<a id='8f996b48-3371-4f84-9261-783dddd17268'></a>

DiPiro J et al., ed. New York: McGraw-Hill Education; 2014.

<a id='8198433a-5193-4f98-968f-fd6f8162dfb0'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='5f6a082b-e691-47c2-aaa2-7c8652aad7f5'></a>

<::logo:
ADDITIONAL FORMULAS
A brown rectangular banner features white text and a white line-art illustration depicting a medical feeding tube connected to a human head.::>

<a id='e7dcb860-a197-41d3-b7c6-b5cf392d0ee7'></a>

<table id="10-1">
<tr><td id="10-2">Disorder</td><td id="10-3">Compensatory Response</td></tr>
<tr><td id="10-4">Acute Respiratory Acidosis</td><td id="10-5">1 mEq/L increase in HCO₃⁻ for every 10 mm Hg rise in PCO₂</td></tr>
<tr><td id="10-6">Chronic Respiratory Acidosis</td><td id="10-7">3 mEq/L increase in HCO₃⁻ for every 10 mm Hg rise in PCO₂</td></tr>
<tr><td id="10-8">Acute Respiratory Alkalosis</td><td id="10-9">2 mEq/L decrease in HCO₃⁻ for every 10 mm Hg fall in PCO₂</td></tr>
<tr><td id="10-a">Chronic Respiratory Alkalosis</td><td id="10-b">4 mEq/L decrease in HCO₃⁻ for every 10 mm Hg fall in PCO₂</td></tr>
</table>

<a id='e902431c-98c5-4f84-80a4-e22037e3a4bf'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='7b31fbc0-61ee-429b-85c8-e0135caf70fb'></a>

MIXED DISORDER <::illustration of a person's head with an IV drip and a nasal tube: figure::>

<a id='d7df9706-6aad-4b7c-9bbf-67f07a25ca3e'></a>

* When two or more primary acid-base disorders occur simultaneously
* Suspect if blood gas values are inappropriate for compensation
* Examples:
  * Patient with sepsis and diabetic ketoacidosis
  * Patient with COPD and volume depletion secondary to loop diuretics

<a id='310c3c65-14ba-4078-9bc9-01fa1aae2e53'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='095ec1d6-b64f-4bbf-bf5d-7bd19a0f4dbf'></a>

## SELF-ASSESSMENT #2

A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disorder?

A. Decreased pH, decreased HCO₃⁻
B. Decreased pH, increased PCO₂
C. Increased pH, increased HCO₃⁻
D. Increased pH, decreased PCO₂

NUTRITION SUPPORT CERTIFICATE

<a id='bec6d6f9-263f-4691-93da-c1bfe7e29ba4'></a>

# METABOLIC ACIDOSIS

*   Decreased pH (< 7.35) due to decreased plasma HCO₃⁻ (< 24 mEq/L)
    *   Loss of bicarbonate-rich fluids
    *   Excessive administration of non-alkali based fluids
    *   Consumption or accumulation of acids (H+)
*   Pulmonary compensation
    *   Increase respiratory rate
    *   Decrease pCO₂
*   Classified as normal or elevated anion gap

NUTRITION SUPPORT
CERTIFICATE

<a id='5d38b610-1a0a-4bb9-bd0a-f484889cd2e3'></a>

## ANION GAP (AG)

*   Estimates the difference between measured and unmeasured major ECF cations and anions
*   AG = Na+ - (Cl⁻ + HCO₃⁻)
*   Normal AG = 3-11 mEq/L
    *   AG > 17-20 mEq/L indicates accumulation of unmeasured anions
    *   AG > 20-25 mEq/L indicates significant organic acidosis
*   1:1 ratio between anions in blood
    *   Normal AG: Every 1 mEq/L &uarr; in Cl⁻ should result in 1 mEq/L &darr; in HCO₃⁻
    *   Elevated AG: Every 1-point &uarr; in AG should result in 1 mEq/L &darr; in HCO₃⁻

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.

NUTRITION SUPPORT
CERTIFICATE

<a id='ceef2ea0-f891-499e-85d7-3ef0792c8f37'></a>

<table id="12-1">
<tr><td id="12-2" colspan="2">Etiology: Normal-Anion Gap Metabolic Acidosis</td></tr>
<tr><td id="12-3">U</td><td id="12-4">Ureteroenterostomy (urinary diversion)</td></tr>
<tr><td id="12-5">S</td><td id="12-6">Small bowel (pancreatic/biliary) fistula</td></tr>
<tr><td id="12-7">E</td><td id="12-8">Excessive chloride salts</td></tr>
<tr><td id="12-9">D</td><td id="12-a">Diarrhea</td></tr>
<tr><td id="12-b">C</td><td id="12-c">Carbonic anhydrase inhibitors (acetazolamide)</td></tr>
<tr><td id="12-d">A</td><td id="12-e">Adrenal insufficiency/aldosterone deficiency</td></tr>
<tr><td id="12-f">R</td><td id="12-g">Renal tubular acidosis</td></tr>
</table>
Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

<a id='086cc6a7-b391-4acb-9c4d-13302f684be0'></a>

CAPTION ERROR

<a id='024aee7b-9c82-4174-81c2-292f36aba384'></a>

* Urine chemistries and urine pH are helpful in identifying specific types of renal tubular disorders
* Urinary anion gap (UAG) = (UNa+ + UK+) – UCI = 0 mEq/L

<a id='e65442f7-01b3-4a66-9e5d-d31d60bc8062'></a>

<table id="13-1">
<tr><td id="13-2">UAG</td><td id="13-3">Serum K</td><td id="13-4">Urine pH</td><td id="13-5">Diagnosis</td></tr>
<tr><td id="13-6">Negative</td><td id="13-7">Normal</td><td id="13-8">< 5.5</td><td id="13-9">Normal</td></tr>
<tr><td id="13-a">Negative</td><td id="13-b">Normal/Low</td><td id="13-c">> 5.5</td><td id="13-d">Gl bicarbonate loss</td></tr>
<tr><td id="13-e">Positive</td><td id="13-f">Elevated</td><td id="13-g">< 5.5</td><td id="13-h">Selective Aldosterone Deficiency</td></tr>
<tr><td id="13-i">Positive</td><td id="13-j">Normal/Low</td><td id="13-k">> 5.5</td><td id="13-l">Classic RTA</td></tr>
<tr><td id="13-m">Positive</td><td id="13-n">Elevated</td><td id="13-o">> 5.5</td><td id="13-p">Hyperkalemic Distal RTA</td></tr>
</table>

<a id='98a52f8d-a355-4d48-8fc0-dffe6eca036d'></a>

Batlle, et al. N Engl J Med 1988;318:594-599.

<a id='1f88a0b9-6829-400d-bae2-e924fd616f81'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='a0846d66-63e6-455c-97ce-1ba9c0d2cb26'></a>

<table id="13-q">
<tr><td id="13-r" colspan="2">Etiology: Elevated-Anion Gap Metabolic Acidosis</td></tr>
<tr><td id="13-s">M</td><td id="13-t">Methanol ingestion</td></tr>
<tr><td id="13-u">U</td><td id="13-v">Uremia (renal failure)</td></tr>
<tr><td id="13-w">D</td><td id="13-x">Diabetic ketoacidosis (alcohol and starvation ketoacidosis)</td></tr>
<tr><td id="13-y">P</td><td id="13-z">Propylene glycol ingestion</td></tr>
<tr><td id="13-A">I</td><td id="13-B">Isoniazid</td></tr>
<tr><td id="13-C">L</td><td id="13-D">Lactic acidosis</td></tr>
<tr><td id="13-E">E</td><td id="13-F">Ethylene glycol ingestion</td></tr>
<tr><td id="13-G">S</td><td id="13-H">Salicylate overdose</td></tr>
</table>

<a id='a617c40a-6185-4f40-91cf-f966aa881b3a'></a>

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239–47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

<a id='483cf008-0702-4708-a8d2-72d111974389'></a>

METABOLIC ACIDOSIS TREATMENT

*   Identify and treat/remove underlying cause(s)
*   Steroids (adrenal insufficiency)
*   Antidiarrhea, antisecretory agents (diarrhea/fistula)
*   Discontinue chloride-based fluids
*   Adjust PN to have higher acetate:chloride salt ratio
*   Fluid resuscitation, insulin (diabetic ketoacidosis)
*   Fluid resuscitation, antimicrobial agents (sepsis)
*   Bicarbonate replacement (oral or intravenous)

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.

NUTRITION SUPPORT
CERTIFICATE

<a id='93189729-1e8d-4b14-8d4b-321ec6836aba'></a>

## SELF-ASSESSMENT #3

A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate compensatory response?

option A. Increase in respiratory rate: [ ]
option B. Decrease in respiratory rate: [ ]
option C. Increase bicarbonate reabsorption: [ ]
option D. Decrease bicarbonate reabsorption: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='451d81f3-25d4-4e80-820a-77f5f1d4c60c'></a>

METABOLIC ALKALOSIS

*   Increased pH (> 7.45) due to increased plasma HCO3- (> 24 mEq/L)
    *   Excessive loss of H+ from the kidney or stomach
    *   Ingestion/administration of bicarbonate-rich fluids
    *   Loss of fluid containing chloride
*   Pulmonary compensation
    *   Decrease respiratory rate
    *   Increase pCO2
*   Classified as saline responsive (uCl < 10 mEq/L) and saline resistant (uCl > 10 mEq/L)

NUTRITION SUPPORT
CERTIFICATE

<a id='5b107e6c-bd39-4d68-9308-2234f4ec7ea4'></a>

ETIOLOGY

Saline-responsive
*   Diuretics (loops and thiazides)
*   Gastric losses (emesis, nasogastric suction, gastric tube losses)
*   Exogenous alkali administration (acetate salts in PN, bicarbonate infusions, Ringers lactate)
*   Alkalosis associated with mild hypokalemia
*   Villous adenoma of the colon

Saline-resistant
*   Normotensive patients
    *   Potassium depletion
    *   Hypercalcemia
*   Hypertensive patients
    *   Mineralocorticoid excess
    *   Large licorice intake

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='fcd362bc-5bbf-407e-b92d-6faaf27b5711'></a>

<::METABOLIC ALKALOSIS TREATMENT with line-art icons of an IV drip and a human head : figure::>

<a id='cf83bea0-3747-44a4-897a-856e26f2e991'></a>

- Identify and treat/remove underlying cause(s)
- Volume replacement
- Discontinue bicarbonate (acetate)-based fluids
- Adjust PN to have higher chloride:acetate salt ratio
- Antiemetics, acid suppressive therapy (emesis, high NG output)
- Potassium replacement
- Carbonic anhydrase inhibitors (acetazolamide)
- Spironolactone (mineralocorticoid excess)
- Hydrochloric acid (severe cases)

<a id='982453da-d70d-4fc1-ba4f-d54bde5d4d79'></a>

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.

<a id='c8f54429-a678-47ee-aeca-58967962d7bd'></a>

> acid (severe cases)

lin Pract. 2014; 30:14-20.

NUTRITION SUPPORT
CERTIFICATE

<a id='283a2ade-4902-4e2d-a801-ef29864ebdc7'></a>

SELF-ASSESSMENT #4

Which of the following diuretics is NOT associated with metabolic alkalosis?

A. Hydrochlorothiazide
B. Bumetanide
C. Acetazolamide
D. Furosemide

NUTRITION SUPPORT
CERTIFICATE

<a id='bee3e41c-0131-45ee-afeb-82f034836797'></a>

# RESPIRATORY ACIDOSIS

*   Decreased pH (< 7.35) due to increased pCO₂ (> 40 mmHg)
    *   Respiratory failure
    *   Inadequate excretion of pCO₂
*   Renal compensation
    *   Decreased bicarbonate excretion (increasing HCO₃⁻)
*   Acute versus chronic

NUTRITION SUPPORT
CERTIFICATE

<a id='fcfc8595-e808-46ca-aeb3-d6490c422587'></a>

## RESPIRATORY ACIDOSIS ETIOLOGY

### Acute Respiratory Acidosis
*   Acute airway disorders (airway obstruction, asthma/COPD exacerbation)
*   Acute central nervous system depression (drug overdose, head trauma, stroke, infections)
*   Acute neuromuscular disorders (Guillain-Barre, spinal cord injury, neuromuscular blocking agents)
*   Acute respiratory disorder (pneumonia, pulmonary edema, pulmonary embolus, hemothorax, pneumothorax)

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='245e8dbf-2be8-479b-aac2-e20f7cc6c6db'></a>

RESPIRATORY ACIDOSIS ETIOLOGY

<a id='8f6f6db5-1017-4461-b14e-b08595ae1382'></a>

Chronic Respiratory Acidosis

* Asthma
* COPD, emphysema
* Obstructive sleep apnea
* Hypoventilation syndromes
* Diaphragmatic paralysis
* Myasthenia gravis
* Amyotrophic lateral sclerosis
* Spinal cord injury
* Multiple sclerosis
* Muscular dystrophy
* Poliomyelitis
* Kyphoscoliosis
* Hypothyroidism

<a id='01f7b1cf-8a1e-4114-9f8d-8ed6c026b7c5'></a>

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

<a id='ef2a0dba-5212-46e9-90c4-eafa1b0b2fa7'></a>

<::A visual element with a brown and orange shaded, rising slope design. On the left, the text "-11." is present. On the right, the text "NUTRITION SUPPORT CERTIFICATE" is displayed.: figure::>

<a id='20b23307-74b5-48b5-91b5-13a606bb865f'></a>

RESPIRATORY ACIDOSIS
TREATMENT

*   Identify and treat/remove underlying cause(s)
*   Ventilatory support
*   Respiratory treatments
*   Antimicrobial therapy (as appropriate)
*   Antidotes (overdose)
*   Alkali therapy in severe acidosis

<a id='32042c8d-5357-4391-a1ee-b2009649f843'></a>

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.

<a id='6590c60a-7c70-4410-96dc-c3a1785033e0'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='83b170f0-5add-42ec-b7ff-66972767ed5a'></a>

RESPIRATORY ALKALOSIS

*   Increased pH (> 7.45) due to decreased pCO2 (< 40 mmHg)
    *   Respiratory stimulation
    *   Increase exhalation of pCO2
*   Renal compensation
    *   Increased bicarbonate excretion (decreasing HCO3-)
*   Acute versus chronic

NUTRITION SUPPORT
CERTIFICATE

<a id='8667bcf2-33ac-448e-b055-55b603997ab4'></a>

**RESPIRATORY ALKALOSIS**
**ETIOLOGY**

*   Central nervous system disorders
    *   Anxiety, pain, infections, head trauma, malignancy, cerebrovascular disease
*   Hypoxia, high altitude
*   Lung disorder
    *   Pneumonia, pulmonary edema, pulmonary embolism, asthma, hyperventilation, interstitial fibrosis
*   Mechanical ventilation

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='37bd6876-dbc8-4f48-87e3-fff16d0f5be1'></a>

CAPTION ERROR

<a id='e3689167-e260-4465-b935-d9bacc439648'></a>

*   Medications
    *   Xanthine derivatives, nicotine, catecholamines, salicylates
*   Pregnancy
*   Cirrhosis
*   Sepsis

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.
Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47.
Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11.

NUTRITION SUPPORT
CERTIFICATE

<a id='4ee870c3-61e9-4eeb-88f9-7af84b54233c'></a>

# RESPIRATORY ALKALOSIS TREATMENT

* Identify and treat/remove underlying cause(s)
* Ventilator support
* Respiratory depressants
* Reassurance
* Antimicrobial therapy (as appropriate)

<a id='22a7ee40-18b5-4017-b5f4-727a044ff16b'></a>

Ayers P et al. Nutr Clin Pract. 2014; 30:14-20.

<a id='03efdbfc-845f-42ea-9c63-ef60aa9fc3d6'></a>

NUTRITION SUPPORT
CERTIFICATE

<a id='7a2b11b6-675c-4d00-8488-497f6819abe4'></a>

CAPTION ERROR

<a id='9c4e5e7a-0a44-4d5b-ab75-275d683b34a3'></a>

- RK is a 55 year old male home PN patient who presents to the Emergency
Department for hypovolemia secondary to multiple days of high volume emesis.
- Laboratory values:

<table id="21-1">
<tr><td id="21-2">Na: 139 mEq/L</td><td id="21-3">Glucose: 122 mg/dL</td></tr>
<tr><td id="21-4">K: 3.7 mEq/L</td><td id="21-5">ABG:</td></tr>
<tr><td id="21-6">Cl: 98 mEq/L</td><td id="21-7">pH: 7.46</td></tr>
<tr><td id="21-8">CO2: 34 mEq/L</td><td id="21-9">pCO2: 46 mmHg</td></tr>
<tr><td id="21-a">BUN: 21 mg/dL</td><td id="21-b">PO2: 92 mmHg</td></tr>
<tr><td id="21-c">Cr: 0.9 mg/dL</td><td id="21-d">HCO₃: 34 mmol/L</td></tr>
</table>

NUTRITION SUPPORT
CERTIFICATE

<a id='5b5e0cab-db04-4de8-bdbf-a5624baeba83'></a>

SELF-ASSESSMENT #1, CONT.

Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?

option A. Initiate mechanical ventilation: [ ]
option B. Increase chloride salts in the PN: [ ]
option C. Increase acetate salts in the PN: [ ]
option D. Decrease calorie content of PN: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='7f742d00-f57e-4fde-bf32-8c4625a4e0d4'></a>

SELF-ASSESSMENT #1, CONT. (Illustration of a person's head with a nasal swab and an IV drip)

<a id='40ddd882-6588-40c9-a963-88fcdf8e6c20'></a>

Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?

option A. Initiate mechanical ventilation: [ ]
option B. Increase chloride salts in the PN: [x]
option C. Increase acetate salts in the PN: [ ]
option D. Decrease calorie content of PN: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='624cdf96-8c9e-4eb3-828e-3901b53b8e53'></a>

# SELF-ASSESSMENT #2

A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disorder?

A. Decreased pH, decreased HCO₃⁻
B. Decreased pH, increased PCO₂
C. Increased pH, increased HCO₃⁻
D. Increased pH, decreased PCO₂

NUTRITION SUPPORT
CERTIFICATE

<a id='13471579-83d7-42be-8f23-0ac439256ba8'></a>

## SELF-ASSESSMENT #2

A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disorder?

option A. Decreased pH, decreased HCO₃⁻: [x]
option B. Decreased pH, increased PCO₂: [ ]
option C. Increased pH, increased HCO₃⁻: [ ]
option D. Increased pH, decreased PCO₂: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='69e1e17b-9d4c-4954-a859-24ef51ad3fd2'></a>

## SELF-ASSESSMENT #3

A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate compensatory response?

option A. Increase in respiratory rate: [ ]
option B. Decrease in respiratory rate: [ ]
option C. Increase bicarbonate reabsorption: [ ]
option D. Decrease bicarbonate reabsorption: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='1243f013-8375-4d02-b9b0-551ee23fa819'></a>

# SELF-ASSESSMENT #3

A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate compensatory response?

option A. Increase in respiratory rate: [x]
option B. Decrease in respiratory rate: [ ]
option C. Increase bicarbonate reabsorption: [ ]
option D. Decrease bicarbonate reabsorption: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='9769eecf-28dd-4b55-a4c1-17f03dced0fe'></a>

## SELF-ASSESSMENT #4

Which of the following diuretics is NOT associated with metabolic alkalosis?

A. Hydrochlorothiazide
B. Bumetanide
C. Acetazolamide
D. Furosemide

NUTRITION SUPPORT
CERTIFICATE

<a id='18f223d0-d3fc-45ab-94de-fd0ad72511bb'></a>

## SELF-ASSESSMENT #4

Which of the following diuretics is NOT associated with metabolic alkalosis?

option A. Hydrochlorothiazide: [ ]
option B. Bumetanide: [ ]
option C. Acetazolamide: [x]
option D. Furosemide: [ ]

NUTRITION SUPPORT
CERTIFICATE

<a id='75c8a352-e6ad-492f-991e-26e253bf6d59'></a>

## CONCLUSIONS

*   A thorough history and physical, including medication review, is important for identification and diagnosis of acid-base disorders.
*   Knowledge of causes of acid-base disorders will help in determining appropriate prevention and treatment plan development.
*   Development of a nutrition care plan should be done using a systematic approach including comorbid states, medication therapy, and changes in clinical status.

NUTRITION SUPPORT
CERTIFICATE

<a id='f742bb8c-2526-49b6-b5eb-4f5a100565c6'></a>

# REFERENCES

* Adrogue, HJ, Gennari FJ, Galla JH et al. Assessing acid-base disorders. *Kidney Int.* 2009; 76:1239–47.
* Al-Jaghbeer M and Kellum JA. Acid-base disturbances in intensive unit patients: etiology, pathophysiology, and treatment. *Nephrol Dial Transplant.* 2015; 30:1104–11.
* Ayers P and Dixon C. Simple acid-base tutorial. *JPEN J Parent Enteral Nutr.* 2012; 36:18–23.
* Ayers P, Dixon C, Mays A. Acid-base disorders: learning the basics. *Nutr Clin Pract.* 2014; 30:14–20.

NUTRITION SUPPORT
CERTIFICATE

<a id='c7a81140-ceec-40a5-9743-046985e2a170'></a>

## REFERENCES, CONT.

*   Battle DC, Hizon M, Cohen E, et al. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med. 1988; 318:594-99.
*   Canada TW and Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 3rd ed. Silver Spring, MD: A.S.P.E.N.; 2017:113-37.
*   DiPiro JT, Talbert RL, Yee G et al., eds. Pharmacotherapy: a pathophysiologic approach. 8th ed. New York: McGraw-Hill Education; 2014.
*   Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70.

NUTRITION SUPPORT
CERTIFICATE

<a id='11994a11-dec6-454a-a2a2-ff0111f2413e'></a>

<::A brown background with a diagonal lighter brown band at the bottom. On the right side, there are white line art illustrations depicting medical nutrition support. These include a profile of a human head with a nasogastric tube inserted, and an IV bag connected to a tube, likely representing parenteral nutrition. Faint, blurred outlines of similar medical equipment are visible in the background. At the bottom right, there are two logos: "ashp" and "aspen".
: diagram::>
NUTRITION SUPPORT
CERTIFICATE

<a id='bf8f845a-d830-435c-8acf-12eb401db263'></a>

<::A headshot of a smiling woman with long brown hair, wearing a black top and a silver necklace. She is looking directly at the camera. The background is a gradient of blue and gray.: figure::>

<a id='d2bbe724-6cbf-4153-926a-9fc28906cf05'></a>

Anne M. Tucker, Pharm.D., BCNSP
Clinical pharmacy Specialist
University of Texas MD Anderson Cancer Center
Houston, Texas

<a id='a22e2a3c-2b73-40d4-b093-8ba4427dca20'></a>

<::figure: Photo of Anne M. Tucker, a woman wearing a black top and a necklace, cropped from the chest up.::>
Anne M. Tucker is clinical pharmacy specialist at the MD Anderson Cancer
Center, Houston, Texas. She received her BS in Chemistry from the
University of Arkansas, Pharm.D. from the University of Arkansas for Medical
Sciences (UAMS) where she also completed residency training. Dr. Tucker has
over 20 years of experience in critical care and nutrition support practice and
participates in didactic and experiential training of students and post-graduate trainees. Her areas of
interest include fluid and electrolyte disorders, nutrition support in critically ill cancer patients, and the
promotion of safe parenteral nutrition practices.

<a id='a6b85011-1090-46f1-8dac-f7670daa26f7'></a>

Dr. Tucker is currently the Chair of the American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee and President of the Texas Gulf Coast ASPEN Chapter. She is also a member and abstract reviewer for American Society of Health-System Pharmacists and Society of Critical Care Medicine. Past leadership includes Chair and member for the Board of Pharmacy Specialties Nutrition Support Specialty Council, Chair and Secretary of the ASPEN Pharmacy Practice Section, Chair of the ASPEN Self-Assessment Committee, Chair for the ASPEN Task Force for Revision of Nutrition Support Pharmacist Standards, and member of the ASPEN Parenteral Nutrition Safety Committee. She is a regular presenter at Clinical Nutrition Week and was most recently involved as an editor and author of the ASPEN Fluid, Electrolytes and Acid-Base Disorders Handbook.

<a id='f7d29750-a7aa-431e-b1b9-87f9d085e123'></a>

## Relevant Financial Relationship Disclosure

In accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

<a id='ade7d8b4-6482-4d24-bae4-0b40f273d4fb'></a>

The following persons in control of this activity's content have relevant financial relationships:
* Phil Ayers: Fresenius Kabi, consultant and speaker
* David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; CVS/OptionCare, consultant; Alcresta, consultant and speaker
* Andrew Mays: Fresenius Kabi, speaker
* Jay Mirtallo: Fresenius Kabi, consultant
* Kris Mogensen: Baxter, speaker; Thrive Rx, advisory board; Pfizer, advisory board

<a id='18e1c001-d2a5-452a-ae14-d7eac2778d9e'></a>

All other persons in control of content do not have any relevant financial relationships with an ineligible company.

<a id='6fbe4f6e-50cf-4232-80b7-0222792863e7'></a>

As required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.

<a id='47b363dd-ba76-4e46-85ad-a0c1168b916c'></a>

### Methods and CE Requirements
---
This online activity consists of a combined total of 12 learning modules. Pharmacists and physicians are eligible to receive a total of 20 hours of continuing education credit by completing all 12 modules within this certificate.

<a id='7930a9b7-ac3c-4208-9111-517f0f54e10b'></a>

Participants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center http://elearning.ashp.org. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.

<a id='2f16353d-4a4b-4573-bd3f-5961db909b9c'></a>

**Important Note–ACPE 60 Day Deadline:**
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

<a id='92a3f378-c9f5-411f-ab8f-79897f1408cc'></a>

## System Technical Requirements
---
Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating websites.

<a id='54c41677-a176-4b36-b999-fc6247964009'></a>

View Frequently Asked Questions for more information.